Characteristics of deaths associated with kratom use.


Journal

Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 21 8 2019
medline: 13 8 2020
entrez: 21 8 2019
Statut: ppublish

Résumé

Kratom ( This study details the characteristics of such fatalities and provides a 'state-of-the-art' review. UK cases were identified from mortality registers by searching with the terms 'kratom', 'mitragynine', etc. Databases and online media were searched using these terms and 'death', 'fatal*', 'overdose', 'poisoning', etc. to identify additional cases; details were obtained from relevant officials. Case characteristics were extracted into an Excel spreadsheet, and analysed employing descriptive statistics and thematic analysis. Typical case characteristics ( These findings add substantially to the knowledge base on kratom-associated deaths; these need systematic, accurate recording. Kratom's safety profile remains only partially understood; toxic and fatal levels require quantification.

Sections du résumé

BACKGROUND
Kratom (
AIMS
This study details the characteristics of such fatalities and provides a 'state-of-the-art' review.
METHODS
UK cases were identified from mortality registers by searching with the terms 'kratom', 'mitragynine', etc. Databases and online media were searched using these terms and 'death', 'fatal*', 'overdose', 'poisoning', etc. to identify additional cases; details were obtained from relevant officials. Case characteristics were extracted into an Excel spreadsheet, and analysed employing descriptive statistics and thematic analysis.
RESULTS
Typical case characteristics (
CONCLUSIONS
These findings add substantially to the knowledge base on kratom-associated deaths; these need systematic, accurate recording. Kratom's safety profile remains only partially understood; toxic and fatal levels require quantification.

Identifiants

pubmed: 31429622
doi: 10.1177/0269881119862530
doi:

Substances chimiques

Illicit Drugs 0
Plant Extracts 0
Secologanin Tryptamine Alkaloids 0
mitragynine EP479K822J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1102-1123

Auteurs

John M Corkery (JM)

Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.

Peter Streete (P)

Hampshire Scientific Service, Southsea, UK.

Hugh Claridge (H)

National Programme on Substance Abuse Deaths, Population Health Research Institute, St George's, University of London, London, UK.

Christine Goodair (C)

National Programme on Substance Abuse Deaths, Population Health Research Institute, St George's, University of London, London, UK.

Duccio Papanti (D)

Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.

Laura Orsolini (L)

Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.

Fabrizio Schifano (F)

Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.

Kanav Sikka (K)

Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.

Sophie Körber (S)

Department of Pharmaceutical Science, University of Basel, Basel, Switzerland.

Amy Hendricks (A)

Retired Forensic Pathology Technician, Santa Clara County, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH